Market Research Logo

Adamed Sp. z o.o. - Product Pipeline Review - 2015

Adamed Sp. z o.o. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Adamed Sp. z o.o. - Product Pipeline Review - 2015’, provides an overview of the Adamed Sp. z o.o.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Adamed Sp. z o.o.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Adamed Sp. z o.o. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Adamed Sp. z o.o.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Adamed Sp. z o.o.’s pipeline products
Reasons to buy
  • Evaluate Adamed Sp. z o.o.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Adamed Sp. z o.o. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Adamed Sp. z o.o.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Adamed Sp. z o.o. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Adamed Sp. z o.o.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Adamed Sp. z o.o. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Adamed Sp. z o.o. Snapshot
Adamed Sp. z o.o. Overview
Key Information
Key Facts
Adamed Sp. z o.o. - Research and Development Overview
Key Therapeutic Areas
Adamed Sp. z o.o. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Adamed Sp. z o.o. - Pipeline Products Glance
Adamed Sp. z o.o. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Adamed Sp. z o.o. - Drug Profiles
ADN-06
Product Description
Mechanism of Action
R&D Progress
ADN-0965
Product Description
Mechanism of Action
R&D Progress
ADN-1184
Product Description
Mechanism of Action
R&D Progress
ADN-2013
Product Description
Mechanism of Action
R&D Progress
ADN-3662
Product Description
Mechanism of Action
R&D Progress
ADO-514
Product Description
Mechanism of Action
R&D Progress
ADN-2157
Product Description
Mechanism of Action
R&D Progress
ONCO-3CLA
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Schizophrenia
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Agonize mGluR2 for Anxiety Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibits MDM2 and MDM4 for Cancer
Product Description
Mechanism of Action
R&D Progress
Adamed Sp. z o.o. - Pipeline Analysis
Adamed Sp. z o.o. - Pipeline Products by Target
Adamed Sp. z o.o. - Pipeline Products by Molecule Type
Adamed Sp. z o.o. - Pipeline Products by Mechanism of Action
Adamed Sp. z o.o. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Adamed Sp. z o.o., Key Information
Adamed Sp. z o.o., Key Facts
Adamed Sp. z o.o. - Pipeline by Indication, 2015
Adamed Sp. z o.o. - Pipeline by Stage of Development, 2015
Adamed Sp. z o.o. - Monotherapy Products in Pipeline, 2015
Adamed Sp. z o.o. - Preclinical, 2015
Adamed Sp. z o.o. - Discovery, 2015
Adamed Sp. z o.o. - Pipeline by Target, 2015
Adamed Sp. z o.o. - Pipeline by Molecule Type, 2015
Adamed Sp. z o.o. - Pipeline Products by Mechanism of Action, 2015
Adamed Sp. z o.o., Subsidiaries
List of Figures
Adamed Sp. z o.o. - Pipeline by Top 10 Indication, 2015
Adamed Sp. z o.o. - Pipeline by Stage of Development, 2015
Adamed Sp. z o.o. - Monotherapy Products in Pipeline, 2015
Adamed Sp. z o.o. - Pipeline by Top 10 Target, 2015
Adamed Sp. z o.o. - Pipeline by Top 10 Molecule Type, 2015
Adamed Sp. z o.o. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report